Seth Klarman bails out of Targacept (TRGT), an amended 13G indicating Baupost Group exited its position at Q1's end. The move was almost certainly driven by the ending of development of Targacept's diabetes drug, along with AstraZeneca giving up on an anti-depressant it was developing with the company.
Seth Klarman bails out of Targacept (TRGT), an amended 13G indicating Baupost Group exited its...
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs